Mark Shearman
2021
Compensation breakdown
Bonus | $247,500 |
---|---|
Non-Equity Incentive Plan | $133,909 |
Option Awards | $1,299,984 |
Salary | $253,077 |
Stock Awards | $1,609,963 |
Other | $5,405 |
Total | $3,549,838 |
Shearman received $1.6M in stock awards, accounting for 45% of the total pay in 2021.
Shearman also received $247.5K in bonus, $133.9K in non-equity incentive plan, $1.3M in option awards, $253.1K in salary and $5.4K in other compensation.
Rankings
In 2021, Mark Shearman's compensation ranked 3,760th out of 12,412 executives tracked by ExecPay. In other words, Shearman earned more than 69.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,760 | 70th |
Manufacturing | 1,533 | 72nd |
Chemicals And Allied Products | 619 | 74th |
Drugs | 548 | 74th |
Biological Products, Except Diagnostic Substances | 143 | 68th |
Pay ratio
Mark Shearman's Pay | $3,549,838 |
---|---|
Median Employee's Pay | $181,354 |
Pay Ratio | 20to 1 |
In 2021, the annual total compensation of Mark Shearman was $3,549,838.
The annual total compensation of the median employee at Editas Medicine was $181,354.
The ratio of Mark Shearman's pay to the pay of median employee was therefore 20 to one.
Shearman's colleagues
We found five more compensation records of executives who worked with Mark Shearman at Editas Medicine in 2021.
2021
James Mullen
Editas Medicine
Chief Executive Officer
2021
Michelle Robertson
Editas Medicine
Chief Financial Officer
2021
Bruce Eaton
Editas Medicine
Executive Vice President and Chief Business Officer
2021
Lisa Michaels
Editas Medicine
Chief Medical Officer
2021
Cynthia Collins
Editas Medicine